title: [Anaphylactic shock after i.v. verapamil].
abstract: A 61-year-old woman who was being treated with verapamil because of atrial fibrillation with rapid ventricular rate, went into anaphylactic shock. Verapamil is safe and effective for treating supraventricular tachyarrhythmias and serious adverse effects are uncommon. However, hypotension, cardiogenic shock, bradycardia and precipitation or aggravation of heart failure have been described. The patient presented was successfully treated with corticosteroids and antihistaminics.
authors.forename: H
authors.initials: H
authors.lastname: Rabinowitz
authors.forename: B
authors.initials: B
authors.lastname: Habot
authors.forename: A
authors.initials: A
authors.lastname: Fridensohn
authors.forename: Z
authors.initials: Z
authors.lastname: Schlesinger
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000707:Anaphylaxis / Q000139:chemically induced* / Q000188:drug therapy; D001281:Atrial Fibrillation / Q000188:drug therapy; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D014700:Verapamil / Q000009:adverse effects*
chemical_list: D000305:Adrenal Cortex Hormones; D006634:Histamine H1 Antagonists; D014700:Verapamil